Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
基本信息
- 批准号:10245059
- 负责人:
- 金额:$ 40.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:A549AT Rich SequenceAddressAdultAnchorage-Independent GrowthArsenicAttenuatedAutomobile DrivingBindingBinding ProteinsBone DevelopmentCRISPR/Cas technologyCarcinogensCategoriesCell NucleusCellsChIP-seqChemicalsChromatin LoopCytoskeletonDNADNA SequenceDevelopmentDown-RegulationEmbryoEmbryonic DevelopmentEpithelial CellsEventExposure toGenesGlandular CellGrantHomologous GeneHumanIn VitroIncidenceKnock-outLaminsLeadLentivirus VectorLower Gastrointestinal TractLungMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of lungMatrix Attachment RegionsMediatingMessenger RNAMetal CarcinogenesisMetalsMicroRNAsNickelNormal tissue morphologyNuclear EnvelopeNuclear MatrixNuclear Matrix-Associated ProteinsNuclear PoreNuclear ProteinsNude MicePaperPathway interactionsPlayPost-Translational Protein ProcessingProcessProtein FamilyProteinsRegulationRoleSamplingShapesStructureTissuesTranslationsUp-RegulationWorkcancer cellcancer typecarcinogenesiscarcinogenicitycell transformationcellular engineeringcraniofacial developmentexperimental studyfallsgene repressioninhibitor/antagonistknock-downlung cancer cellmRNA Stabilitymembermigrationmimeticsneurodevelopmentosteoblast differentiationoverexpressionp38 Mitogen Activated Protein Kinasepreventprotein expressiontranscription factortumortumorigenesis
项目摘要
PROJECT SUMMARY
SATB2 expression is critical for metal carcinogenesis. SATB2 is the only common gene that is upregulated in
BEAS2B cells transformed by various carcinogenic metals and knock-down of SATB2 in normal BEAS2B cells
prevents metal carcinogenesis. Knockdown SATB2 in arsenic (As) or nickel (Ni) transformed cells, results in the
loss in hallmarks of transformation including anchorage independent growth, enhanced cell invasion and
migration. The regulation of SATB2 involves miR-31 and miR23a. RUNX2 transcription factor down regulates
the miRNAs that inhibit SATB2 expression and increases in RUNX2 brought about by exposure to Ni and As
indirectly induces SATB2 by attenuating expression of these translation inhibitory miRs. The mechanisms for
the increase expression of RUNX2 induced following exposure to As and Ni, and in As or Ni transformed cells
will be studied. RUNX2 activation appears to be a critical upstream event that increases SATB2 protein which
maintains cancer hallmarks. RUNX2 will be knocked out in normal BEAS2B to study its role in SATB2 expression
and for cell transformation induced by Ni and As. RUNX2 and antogomers of miR-31 and miRNA 23a will be
overexpressed and the incidence of BEAS2B transformation assessed. These later experiments will address
how these miRNA block the translation of SATB2 mRNA. We will utilize a chemical inhibitor of RUNX2 (A1-10-
104) to study whether cell transformation induced by Ni and As and, cells transformed by overexpress RUNX2
is suppressed. A1-10-104 will also be used to study its effect on xenograph tumor formation in nude mice. We
will use RUNX2 Chip-Seq to identify downstream targets in cells treated with As and Ni or transformed by these
metals, as well as in cells engineered to overexpress RUNX2. SATB2 Chip-Seq will investigate how this
transcription factor maintains cancer hallmarks. We will investigate the RUNX2/miRNA/SATB2 axis in samples
of human lung cancers and surrounding normal tissue. We will study the mechanisms of how Ni and As exposure
induce BEAS2B cell transformation, increase and maintain high levels of RUNX2 mRNA and protein as well as
maintaining the post-translational modifications that are required to activate RUNX2. The mechanisms of how
RUNX2 downregulates miRNA-31 and 23a will be investigated. We will study whether administration of miR-
mimetics (miRNA-31or 23a) in lentivirus vectors, can shrink orthotopic or xenograph tumors induced by BEAS2B
cells transformed with As, Ni or with overexpressed SATB2, compared to A549 lung cancer cells that have
low levels of SATB2.
项目摘要
SATB2表达对于金属癌变至关重要。 SATB2是唯一上调的常见基因
BEAS2B细胞由正常Beas2b细胞中的各种致癌金属和SATB2敲低的转化
防止金属癌变。在砷(AS)或镍(Ni)转化的细胞中敲除SATB2,导致
转型标志的损失,包括锚定独立生长,增强的细胞侵袭和
迁移。 SATB2的调节涉及miR-31和miR23a。 runx2转录因子下调
抑制SATB2表达并增加runx2的miRNA通过暴露于Ni和AS带来的miRNA
通过减弱这些翻译抑制性miR的表达来间接诱导SATB2。机制
暴露于AS和Ni后,Runx2的增加表达,在AS或Ni转化的细胞中
将被研究。 Runx2激活似乎是一个关键的上游事件,它增加了SATB2蛋白
保持癌症标志。 runx2将在正常的BEAS2B中被淘汰,以研究其在SATB2表达中的作用
以及由Ni和AS引起的细胞转化。 miR-31和miRNA 23A的Runx2和Antogomers将是
过表达和评估了BEAS2B转换的发生率。这些后来的实验将解决
这些miRNA如何阻止SATB2 mRNA的翻译。我们将利用Runx2的化学抑制剂(A1-10--
104)研究是否由Ni和AS和AS诱导的细胞转化,通过过表达Runx2转化的细胞
被抑制。 A1-10-104也将用于研究其对裸鼠Xenographing肿瘤形成的影响。我们
将使用runx2芯片seq识别被AS和NI处理的单元格中的下游靶
金属以及用于过表达Runx2的单元格。 SATB2芯片seq将调查如何
转录因子维持癌症标志。我们将研究样品中的runx2/miRNA/satb2轴
人类肺癌和周围正常组织的。我们将研究NI和接触的机制
诱导BEAS2B细胞转化,增加和维持高水平的Runx2 mRNA和蛋白质以及
维护激活Runx2所需的翻译后修改。如何
RUNX2将下调miRNA-31和23A。我们将研究mir-的给药
慢病毒载体中的Mimetics(miRNA-31OR 23A)可以收缩BEES2B诱导的原位或异种肿瘤
与具有AS,Ni或过表达的SATB2相比,与具有A549的肺癌细胞相比
SATB2的低水平。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Max Costa其他文献
Max Costa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Max Costa', 18)}}的其他基金
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
10077549 - 财政年份:2020
- 资助金额:
$ 40.1万 - 项目类别:
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
9899647 - 财政年份:2020
- 资助金额:
$ 40.1万 - 项目类别:
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
10515635 - 财政年份:2020
- 资助金额:
$ 40.1万 - 项目类别:
Persistent transcriptional changes induced by nickel through epigenetic alterations
镍通过表观遗传改变诱导持续转录变化
- 批准号:
10294236 - 财政年份:2020
- 资助金额:
$ 40.1万 - 项目类别:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
- 批准号:
10470848 - 财政年份:2019
- 资助金额:
$ 40.1万 - 项目类别:
Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
砷致癌和组蛋白变体 H3.3 组装的破坏
- 批准号:
10407027 - 财政年份:2019
- 资助金额:
$ 40.1万 - 项目类别:
MEG3 deletion drives lung tumorigenesis due to environmental nickel exposure
由于环境镍暴露,MEG3 缺失导致肺部肿瘤发生
- 批准号:
9852426 - 财政年份:2019
- 资助金额:
$ 40.1万 - 项目类别:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
- 批准号:
10004646 - 财政年份:2019
- 资助金额:
$ 40.1万 - 项目类别:
Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
砷致癌和组蛋白变体 H3.3 组装的破坏
- 批准号:
10631227 - 财政年份:2019
- 资助金额:
$ 40.1万 - 项目类别:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
砷和镍对人肺细胞的致癌作用
- 批准号:
10681242 - 财政年份:2019
- 资助金额:
$ 40.1万 - 项目类别:
相似海外基金
The stage-specific regulation of ameloblastin and enamelin by the distinct nuclear factors
不同核因子对成釉素和釉质的阶段特异性调节
- 批准号:
10804126 - 财政年份:2023
- 资助金额:
$ 40.1万 - 项目类别:
Molecular Assessment of Cause and Consequence of Cellular Senescence in Diverse Midbrain Cell Types in Parkinson's Disease
帕金森病多种中脑细胞类型细胞衰老原因和后果的分子评估
- 批准号:
10662519 - 财政年份:2022
- 资助金额:
$ 40.1万 - 项目类别:
Molecular Assessment of Cause and Consequence of Cellular Senescence in Diverse Midbrain Cell Types in Parkinson's Disease
帕金森病多种中脑细胞类型细胞衰老原因和后果的分子评估
- 批准号:
10521877 - 财政年份:2022
- 资助金额:
$ 40.1万 - 项目类别:
FUNCTIONAL CHARACTERIZATION OF THE PRDM10-ZN FINGER TRANSCRIPTION FACTOR IN EARLY MAMMALIAN DEVELOPMENT
PRDM10-ZN 指转录因子在早期哺乳动物发育中的功能特征
- 批准号:
10477941 - 财政年份:2021
- 资助金额:
$ 40.1万 - 项目类别:
FUNCTIONAL CHARACTERIZATION OF THE PRDM10-ZN FINGER TRANSCRIPTION FACTOR IN EARLY MAMMALIAN DEVELOPMENT
PRDM10-ZN 指转录因子在早期哺乳动物发育中的功能特征
- 批准号:
10617819 - 财政年份:2021
- 资助金额:
$ 40.1万 - 项目类别: